AT
Alphina Therapeutics, Inc.
SEC filingBiotechnology · New Haven, CT
Amount raised$154Ksold at filing
Total offering$10M$9.8M still open
Investors in the raise3count reported to the SEC
FiledMar 16, 2026first sale Feb 23, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Barbara J FoxExecutive Officer, Director
Colleen J CuffaroDirector
Nicholas J GalliExecutive Officer, Director
Kevin J RakinDirector
Matthew J CohenDirector
Ranjit J BindraDirector
Executive officers, directors and promoters as listed on the Form D.